机译:佐剂治疗优于拯救治疗治疗,用于病理T2-3N0M0或T1-4N1M0 / T4N0M0自由基手术后食管癌
Chinese Acad Med Sci Canc Hosp &
Inst Natl Canc Ctr Beijing Peoples R China;
Huazhong Univ Sci &
Technol Ctr Canc Union Hosp Tongji Med Coll Wuhan Hubei Peoples R China;
Chinese Acad Med Sci Canc Hosp &
Inst Natl Canc Ctr Beijing Peoples R China;
Chinese Acad Med Sci Natl Canc Ctr Canc Inst &
Hosp Dept Radiat Oncol Peking Union Med Coll;
Chinese Acad Med Sci Canc Hosp &
Inst Natl Canc Ctr Beijing Peoples R China;
Chinese Acad Med Sci Canc Hosp &
Inst Natl Canc Ctr Beijing Peoples R China;
Peking Union Med Coll Beijing Peoples R China;
Peking Union Med Coll Beijing Peoples R China;
Peking Union Med Coll Beijing Peoples R China;
Chinese Acad Med Sci Canc Hosp &
Inst Natl Canc Ctr Beijing Peoples R China;
Chinese Acad Med Sci Natl Canc Ctr Canc Inst &
Hosp Dept Radiat Oncol Peking Union Med Coll;
Chinese Acad Med Sci Canc Hosp &
Inst Natl Canc Ctr Beijing Peoples R China;
Chinese Acad Med Sci Canc Hosp &
Inst Natl Canc Ctr Beijing Peoples R China;
Chinese Acad Med Sci Canc Hosp &
Inst Natl Canc Ctr Beijing Peoples R China;
Peking Union Med Coll Beijing Peoples R China;
Chinese Acad Med Sci Natl Canc Ctr Canc Inst &
Hosp Dept Radiat Oncol Peking Union Med Coll;
机译:佐剂治疗优于拯救治疗治疗,用于病理T2-3N0M0或T1-4N1M0 / T4N0M0自由基手术后食管癌
机译:在Neoadjuvant ChemorAdootherapy和自由基手术后,局部晚期直肠癌患者是局部晚期直肠癌患者的辅助化疗吗? 系统审查和荟萃分析
机译:对于局部晚期直肠癌,新辅助放化疗和根治性手术后病理完全缓解的患者是否需要辅助化疗?在一个中心对40 ypCR患者进行长期分析
机译:在明确的化学疗法后食管癌持续术前术前CT检查,内窥镜检查和病理诊断的诊断
机译:前列腺癌根治术后前列腺癌生化复发的挽救性外照射治疗中手术切缘阳性部位的重要性
机译:放射治疗局部切除的晚期食管鳞癌的辅助放疗与挽救性放疗的比较和预后分析
机译:佐剂治疗优于拯救治疗治疗,用于病理T2-3N0M0或T1-4N1M0 / T4N0M0自由基手术后食管癌